Leonard S. Schleifer, Bd. Co-Chair, President & CEO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,574 shares at $1015.02 ($1.6M) on 2024-06-06, disclosed to the SEC on 2024-06-10.
Scheduled sale ($1.6M) by Bd. Co-Chair, President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1015.02 | 787 | $799K | 50.0% |
| 2 | $1015.02 | 787 | $799K | 50.0% |
| Total | $1015.02 avg | 1,574 | $1.6M | 100% |
| Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |
| REGN | SELL | 2022-04-04 | $4.1M | — | Filing → |